Sudafed PE Phenylephrine Night

Country: New Zealand

Lingwa: Ingliż

Sors: Medsafe (Medicines Safety Authority)

Ingredjent attiv:

Chlorphenamine maleate 2mg (From Compap CPM-0117); Paracetamol 500mg (180.92mg from Compap L-0093, 319.08mg from Compap CPM-0117); Phenylephrine hydrochloride 5mg equivalent to phenylephrine 4.1 mg;  ;  

Disponibbli minn:

JNTL Consumer Health (New Zealand) Limited

INN (Isem Internazzjonali):

Chlorphenamine maleate 2 mg (From Compap CPM-0117)

Għamla farmaċewtika:

Film coated tablet

Kompożizzjoni:

Active: Chlorphenamine maleate 2mg (From Compap CPM-0117) Paracetamol 500mg (180.92mg from Compap L-0093, 319.08mg from Compap CPM-0117) Phenylephrine hydrochloride 5mg equivalent to phenylephrine 4.1 mg     Excipient: Colloidal silicon dioxide Crospovidone Balance of Compap L-0093 (as Pregelatinised starch, Stearic acid, Povidone and Crospovidone) hydrous Balance of Compap CPM-0117 (as Pregelatinised starch, Stearic acid and Povidone) hydrous Microcrystalline cellulose Opadry orange 85F63129 Pregelatinised maize starch Stearic acid

Tip ta 'preskrizzjoni:

Pharmacy only

Manifatturat minn:

Kongo Chemical Co., Ltd

Indikazzjonijiet terapewtiċi:

For the temporary relief of sinus headache, pain, congestion, and allergic symptoms such as sneezing, blocked or runny nose, itching and watery eyes.

Sommarju tal-prodott:

Package - Contents - Shelf Life: Blister pack, PVD/PVDC and Al foil - 24 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVD/PVDC and Al foil - 48 tablets - 36 months from date of manufacture stored at or below 30°C

Data ta 'l-awtorizzazzjoni:

2013-12-16